Stay updated on Magrolimab Combo in AML Clinical Trial
Sign up to get notified when there's something new on the Magrolimab Combo in AML Clinical Trial page.

Latest updates to the Magrolimab Combo in AML Clinical Trial page
- Check3 days agoChange DetectedThe footer revision identifier changed from v3.7.0 to v3.7.1 while the page continued to display a 403 error.SummaryDifference0.2%

- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedSponsor branding is removed and key study documents are deleted from the page, along with related metadata under Study Documents. This alters the availability of sponsor context and foundational materials describing the trial's design and analysis plan.SummaryDifference17%

- Check24 days agoChange DetectedThe page's revision tag was updated to v3.7.0, indicating a backend or CMS update. No study details or user-facing content appear to be modified by this change.SummaryDifference0.0%

- Check38 days agoChange DetectedThe page's revision tag updated from v3.6.5 to v3.6.6. This indicates a newer version of the page content.SummaryDifference0.0%

- Check59 days agoChange DetectedRevision label updated from v3.6.4 to v3.6.5 for the page/document. This indicates a metadata/version update rather than changes to study content or functionality.SummaryDifference0.0%

- Check73 days agoChange DetectedRevision tag on the page updated from v3.6.3 to v3.6.4. This indicates a small metadata update to the page version.SummaryDifference0.0%

Stay in the know with updates to Magrolimab Combo in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Magrolimab Combo in AML Clinical Trial page.